These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8200078)

  • 21. Sulfation-dependent formation of N-acetylated and deacetylated DNA adducts of N-hydroxy-4-acetylaminobiphenyl in male rat liver in vivo and in isolated hepatocytes.
    van de Poll ML; Venizelos V; Meerman JH
    Carcinogenesis; 1990 Oct; 11(10):1775-81. PubMed ID: 1698568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of DNA adducts in rats exposed to pentachlorophenol.
    Lin PH; La DK; Upton PB; Swenberg JA
    Carcinogenesis; 2002 Feb; 23(2):365-9. PubMed ID: 11872646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro.
    Surh YJ; Liem A; Miller EC; Miller JA
    Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols.
    Arlt VM; Stiborova M; Henderson CJ; Osborne MR; Bieler CA; Frei E; Martinek V; Sopko B; Wolf CR; Schmeiser HH; Phillips DH
    Cancer Res; 2005 Apr; 65(7):2644-52. PubMed ID: 15805261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
    Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
    Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.
    Shibutani S; Shaw PM; Suzuki N; Dasaradhi L; Duffel MW; Terashima I
    Carcinogenesis; 1998 Nov; 19(11):2007-11. PubMed ID: 9855017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA adducts of the ubiquitous environmental contaminant cyclopenta[cd]pyrene.
    Beach AC; Gupta RC
    Carcinogenesis; 1994 May; 15(5):1065-72. PubMed ID: 8200070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of sulfotransferase affecting in vivo genotoxicity and DNA adducts induced by safrole in rat liver.
    Daimon H; Sawada S; Asakura S; Sagami F
    Teratog Carcinog Mutagen; 1997-1998; 17(6):327-37. PubMed ID: 9485541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
    Boberg EW; Miller EC; Miller JA; Poland A; Liem A
    Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.
    Shibutani S; Dasaradhi L; Terashima I; Banoglu E; Duffel MW
    Cancer Res; 1998 Feb; 58(4):647-53. PubMed ID: 9485016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.
    White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH
    Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems.
    Pathak DN; Bodell WJ
    Carcinogenesis; 1994 Mar; 15(3):529-32. PubMed ID: 8118938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation.
    Davis W; Venitt S; Phillips DH
    Carcinogenesis; 1998 May; 19(5):861-6. PubMed ID: 9635875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.
    Werner S; Kunz S; Wolff T; Schwarz LR
    Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Poon GK
    Cancer Res; 1994 Nov; 54(21):5518-22. PubMed ID: 7923188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of specific DNA adducts in the induction of micronuclei by N-hydroxy-2-acetylaminofluorene in rat liver in vivo.
    van de Poll ML; van der Hulst DA; Tates AD; Mulder GJ; Meerman JH
    Carcinogenesis; 1989 Apr; 10(4):717-22. PubMed ID: 2702720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
    Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
    Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
    Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.
    Kaderlik KR; Minchin RF; Mulder GJ; Ilett KF; Daugaard-Jenson M; Teitel CH; Kadlubar FF
    Carcinogenesis; 1994 Aug; 15(8):1703-9. PubMed ID: 8055652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.